Education
About Us
Working with TipRanks
Follow Us
Arcellx, Inc. (ACLX)
:ACLX
Standard Lymphodepletion Regimen, Anito-Cel
Autoimmune Diseases, Neuromuscular Manifestations, Muscular Diseases, Myasthenia Gravis, Muscle Weakness, Autoimmune, Autoimmune Diseases Of The Nervous System
Phase I
Recruiting
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Sep 19, 2024
―
Dexamethasone, Cyclophosphamide, Fludarabine, Pomalidomide, Daratumumab, Bortezomib, Carfilzomib, Anitocabtagene Autoleucel
Multiple Myeloma
Phase III
Recruiting
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma
May 09, 2024
―
Anitocabtagene-Autoleucel
Multiple Myeloma
Phase II
Active Not Recruiting
Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1)
May 12, 2022
―
Anitocabtagene-Autoleucel
Relapsed And Refractory Multiple Myeloma
Phase I
Active Not Recruiting
Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple Myeloma
Oct 17, 2019
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Arcellx, Inc. (ACLX) have in its pipeline
ACLX is currently developing the following drugs: Standard Lymphodepletion Regimen, Anito-Cel, Dexamethasone, Cyclophosphamide, Fludarabine, Pomalidomide, Daratumumab, Bortezomib, Carfilzomib, Anitocabtagene Autoleucel, Anitocabtagene-Autoleucel. These drug candidates are in various stages of clinical development as the company works toward FDA approval.